Hostname: page-component-7b7567c8c-slfcl Total loading time: 0 Render date: 2026-11-19T13:56:30.242Z Has data issue: false hasContentIssue false

Energy-Dependent Rash Triggered by Bilateral Electroconvulsive Therapy: A Rare Case Report

Published online by Cambridge University Press:  31 July 2026

A. Uzturk*
Affiliation:
Department of Psychiatry, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye
I. H. Karakus
Affiliation:
Department of Psychiatry, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye
S. S. Kirlioglu Balcioglu
Affiliation:
Department of Psychiatry, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Electroconvulsive therapy (ECT) induces controlled seizures via electrical stimulation.It is used in severe or treatment-resistant depression, mania, schizophrenia, and schizoaffective disorder(American Psychiatric Association, 2025).Dermatological reactions to ECT are exceedingly rare.Kellner et al. (2015) reported ipsilateral hemifacial erythema during right unilateral ECT.To date, there have been no documented cases of erythematous rashes associated with bilateral ECT.

Objectives

We report a rare case of energy-dependent erythematous rash induced by bilateral temporal ECT.

Methods

A 29 year old woman with treatment-resistant paranoid schizophrenia was hospitalized for aggression, disorganized behavior, seeing images, and hearing voices.She had no history of ECT.On admission, she exhibited decreased self-care, disorganized thinking, irritability, auditory and visual hallucinations, persecutory and mystical delusions, impaired insight. Laboratory tests, urine toxicology, and cranial imaging were normal.

Results

Due to persistent psychotic symptoms despite adequate antipsychotic therapy, bilateral ECT was initiated.Over seven sessions, erythematous rashes appeared on the neck and chest within seconds of electrical stimulation. The rashes resolved within minutes following administration of corticosteroids and antihistamines. Allergy testing for anesthetic agents and latex (latex-specific IgE) yielded negative results. A notable pattern emerged; as the ECT stimulus energy increased, the rash became more pronounced, requiring higher doses or combined regimens of steroids and antihistamines (Table 1).No hemodynamic instability was observed, and ECT was otherwise well tolerated. Marked clinical improvement was noted, with PANSS scores improving from 116 to 75 and BPRS scores from 33 to 18.The patient regained partial insight and was discharged.Image 1:Photo of a patient after anesthesia. A gloved hand holds a mask over the face while an oral tube is visible. The neck is extended and E C G electrodes are attached to the upper chest.Image 2:

A table titled Table 1 detailing E C T session parameters, energy percentages, seizure durations on E E G or E M G, and medications for rashes across seven sessions. See long description.Image 3:Photo of a person

Conclusions

This case illustrates a rare, energy-dependent dermatological reaction during bilateral ECT. Clinical features suggest a mast cell–mediated, IgE-independent process. ECT induces seizures via cortical and subcortical depolarization, which may activate autonomic pathways and trigger mast cell degranulation via neuropeptides (e.g.,substance P,calcitonin gene-related peptide) (Fetahovic et al.,2025). Mast cell mediators increase vascular permeability, causing erythema and edema (Voss et al.,2021). Rash severity correlated with ECT energy, not EEG/EMG seizure duration. The rash was transient, localized, and resolved rapidly with antihistamines and corticosteroids without anaphylaxis. ECT remained effective, improving psychotic symptoms.This case highlights a dose-dependent, manageable dermatological reaction and the neurostimulation–immune system interaction.

Consent: Written informed consent was obtained from the patient and her mother.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.